Who Priority Pathogens List For R&d Of New Antibiotics New! Today

| R&D Focus | Target Priority | |-----------|----------------| | Novel antibiotics (new classes) | Critical priority Gram-negatives | | Oral antibiotics | High priority (e.g., gonorrhea, typhoid) | | Pediatric formulations | All tiers | | Non-traditional therapies (e.g., phages, anti-virulence) | Especially Critical priority | | Rapid diagnostics | All AMR pathogens |

The updated 2024 WHO BPPL covers 24 pathogens across 15 families, reflecting shifting resistance trends and a more comprehensive understanding of global disease burden. 1. Critical Priority: The Most Urgent Threats who priority pathogens list for r&d of new antibiotics

| Pathogen | |----------| | Streptococcus pneumoniae (penicillin-non-susceptible) | | Haemophilus influenzae (ampicillin-resistant) | | Shigella spp. (fluoroquinolone-resistant) | often causing severe

For the full 2024 report, search: "WHO bacterial priority pathogens list 2024" on the WHO official website. who priority pathogens list for r&d of new antibiotics

These pathogens pose the highest threat, often causing severe, life-threatening infections in hospitals and long-term care facilities. Carbapenem-resistant Enterobacterales

(New standalone addition in 2024)